Advancing Precision Medicine for Lung Cancer
Grant award · Australia · Last reported Oct 2024
Source: GrantConnect
Outcomes for patients diagnosed with lung cancer, the most deadly cancer in Australia and worldwide, remain poor. Through an integrated program of clinical trials with novel therapies and translational research to understand and overcome treatment resistance, we will develop new treatment strategies and understand how to match patients with the best treatments at all stages in their disease using
- Status
- Prospective
- Sector
- Education, Hospital, Government
- Location
- Australia
- Updated
- 19 Nov 2026
- Source
- GrantConnect
ConstructChat
Ask ConstructChat about Advancing Precision Medicine for Lung Cancer
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | grant award |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Outcomes for patients diagnosed with lung cancer, the most deadly cancer in Australia and worldwide, remain poor. Through an integrated program of clinical trials with novel therapies and translational research to understand and overcome treatment resistance, we will develop new treatment strategies and understand how to match patients with the best treatments at all stages in their disease using an approach called precision medicine to improve outcomes for people with lung cancer. |
Original sector | Medical Research |
Budget |
Location
Country | Australia |
Source
Source | GrantConnect |
URL |
More Details
Record type | Project |
Sector | Education, Hospital, Government |
Article published date | 2024-12-16 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
